baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out PGR/ DE000VD35UK8 /

2024-04-30 9:35:24 PM	Chg.+0.240	Bid10:00:45 PM	Ask10:00:45 PM	Underlying	Strike price	Expiration date	Option type
0.510EUR	+88.89%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	204.34 USD	2078-12-31	Call

GlobeNewswire 04-30 TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update

GlobeNewswire 04-30 Progressive Announces Investor Relations Call

GlobeNewswire 04-25 Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...

GlobeNewswire 04-25 Opthea to Present at the OIS Retina Innovation Summit at ARVO

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-24 Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...

TeleTrader 04-23 Biden meets AOC amid divide on Israel policy

GlobeNewswire 04-22 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...

GlobeNewswire 04-22 Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...

GlobeNewswire 04-19 Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...

GlobeNewswire 04-18 Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...

GlobeNewswire 04-18 TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...

GlobeNewswire 04-18 Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...

GlobeNewswire 04-18 TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...

GlobeNewswire 04-17 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IP, NXPL, NS, RXMD

GlobeNewswire 04-17 Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm

GlobeNewswire 04-17 Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American ...

GlobeNewswire 04-16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...

GlobeNewswire 04-15 Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatm...

GlobeNewswire 04-15 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...

GlobeNewswire 04-15 TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...

GlobeNewswire 04-12 Progressive Reports March 2024 Results

GlobeNewswire 04-11 PyroGenesis Announces That Lab Strength Tests Achieve 45% Above Target for Green Cement Additive Pro...

GlobeNewswire 04-10 Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024

TeleTrader 04-10 Taiwan appoints Cho Jung-tai as new premier

BVT Knock-Out PGR/ DE000VD35UK8 /

If you wish to receive reply to your feedback, please provide your email address.